Evidence map›Paper›PMID 32986238›Full record

Trial reportCardiology journal2020

On the search for the right definition of heart failure with preserved ejection fraction.

Agnieszka Kapłon-Cieślicka, Karolina Kupczyńska, Piotr Dobrowolski, Błażej Michalski, Miłosz J Jaguszewski, Waldemar Banasiak, Paweł Burchardt, Łukasz Chrzanowski, Szymon Darocha, Justyna Domienik-Karłowicz and 18 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cardiology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 10 institutions in 1 country.

Agnieszka Kapłon-Cieślicka"Club 30", Polish Cardiac Society, Poland. agnieszka.kaplon@gmail.com.
Karolina Kupczyńska"Club 30", Polish Cardiac Society, Poland.
Piotr Dobrowolski"Club 30", Polish Cardiac Society, Poland.
Błażej Michalski"Club 30", Polish Cardiac Society, Poland.
Miłosz J Jaguszewski"Club 30", Polish Cardiac Society, Poland.
Waldemar Banasiak"Club 30", Polish Cardiac Society, Poland.
Paweł Burchardt"Club 30", Polish Cardiac Society, Poland.
Łukasz Chrzanowski"Club 30", Polish Cardiac Society, Poland.
Szymon Darocha"Club 30", Polish Cardiac Society, Poland.
Justyna Domienik-Karłowicz"Club 30", Polish Cardiac Society, Poland.
Jarosław Drożdż"Club 30", Polish Cardiac Society, Poland.
Marcin Fijałkowski"Club 30", Polish Cardiac Society, Poland.
Krzysztof J Filipiak"Club 30", Polish Cardiac Society, Poland.
Marcin Gruchała"Club 30", Polish Cardiac Society, Poland.
Ewa A Jankowska"Club 30", Polish Cardiac Society, Poland.
Piotr Jankowski"Club 30", Polish Cardiac Society, Poland.
Jarosław D Kasprzak"Club 30", Polish Cardiac Society, Poland.
Wojciech Kosmala"Club 30", Polish Cardiac Society, Poland.
Piotr Lipiec"Club 30", Polish Cardiac Society, Poland.
Przemysław Mitkowski"Club 30", Polish Cardiac Society, Poland.
Katarzyna Mizia-Stec"Club 30", Polish Cardiac Society, Poland.
Piotr Szymański"Club 30", Polish Cardiac Society, Poland.
Agnieszka Tycińska"Club 30", Polish Cardiac Society, Poland.
Wojciech Wańha"Club 30", Polish Cardiac Society, Poland.
Maciej Wybraniec"Club 30", Polish Cardiac Society, Poland.
Adam Witkowski"Club 30", Polish Cardiac Society, Poland.
Piotr Ponikowski"Club 30", Polish Cardiac Society, Poland.
On Behalf Of "Club 30" Of The Polish Cardiac Society
Foundation of Cardiac Surgery Development · PLMedical University of Lodz · PLMedical University of Warsaw · PLCentral Clinical Hospital · PLGdańsk Medical University · PLInstitute of Cardiology · PLMedical University of Białystok · PLMedical University of Silesia · PLPoznan University of Medical Sciences · PLWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The definition of heart failure with preserved ejection fraction (HFpEF) has evolved from a clinically based "diagnosis of exclusion" to definitions focused on objective evidence of diastolic dysfunction and/or elevated left ventricular filling pressures. Despite advances in our understanding of HFpEF pathophysiology and the development of more sophisticated imaging modalities, the diagnosis of HFpEF remains challenging, especially in the chronic setting, given that symptoms are provoked by exertion and diagnostic evaluation is largely conducted at rest. Invasive hemodynamic study, and in particular - invasive exercise testing, is considered the reference method for HFpEF diagnosis. However, its use is limited as opposed to the high number of patients with suspected HFpEF. Thus, diagnostic criteria for HFpEF should be principally based on non-invasive measurements. As no single non-invasive variable can adequately corroborate or refute the diagnosis, different combinations of clinical, echocardiographic, and/or biochemical parameters have been introduced. Recent years have brought an abundance of HFpEF definitions. Here, we present and compare four of them: 1) the 2016 European Society of Cardiology criteria for HFpEF; 2) the 2016 echocardiographic algorithm for diagnosing diastolic dysfunction; 3) the 2018 evidence-based H2FPEF score; and 4) the most recent, 2019 Heart Failure Association HFA-PEFF algorithm. These definitions vary in their approach to diagnosis, as well as sensitivity and specificity. Further studies to validate and compare the diagnostic accuracy of HFpEF definitions are warranted. Nevertheless, it seems that the best HFpEF definition would originate from a randomized clinical trial showing a favorable effect of an intervention on prognosis in HFpEF.

Indexed as

CardiologyHeart FailureAgedEchocardiographyExercise TestFemaleHumansMaleStroke Volumeatrial fibrillationdiagnosisdiastolic functionE/e’ ratioleft atrial pressurenatriuretic peptidespulmonary capillary wedge pressure

Identifiers

PMID32986238
PMCPMC8078979
OpenAlexW3087298082

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.